Journal of the American Society of Echocardiography
Volume 22, Issue 11 , Pages 1228-1231 , November 2009

Exercise Echocardiography in Rheumatoid Arthritis: A Case-Control Study

  • Mohammed K. Saghir, MD

      Affiliations

    • Department of Medicine, Mayo Clinic, Rochester, Minnesota
    • ,
  • Christine Attenhofer Jost, MD

      Affiliations

    • Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota
    • ,
  • Kenneth J. Warrington, MD

      Affiliations

    • Division of Rheumatology, Mayo Clinic, Rochester, Minnesota
    • ,
  • Stephen S. Cha, MS

      Affiliations

    • Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota
    • ,
  • Patricia A. Pellikka, MD, FASE

      Affiliations

    • Division of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota
    • Corresponding Author InformationReprint requests: Patricia A. Pellikka, MD, Mayo Clinic, Division of Cardiovascular Diseases, 200 First Street SW, Rochester, MN 55905

References 

  1. Lawrence RC, Helmick CG, Arnett FC, Deyo RA, Felson DT, Giannini EH, et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum. 1998;41:778–799
  2. del Rincon ID, Williams K, Stern MP. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum. 2001;44:2737–2745
  3. Solomon DH, Karlson EW, Rimm EB, Cannuscio CC, Mandl LA, Manson JE, et al. Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation. 2003;107:1303–1307
  4. Warrington KJ, Kent PD, Frye RL, Lymp JF, Kopecky SL, Goronzy JJ, et al. Rheumatoid arthritis is an independent risk factor for multi-vessel coronary artery disease: a case control study. Arthritis Res Ther. 2005;7:R984–R991
  5. Chung CP, Oeser A, Raggi P, Gebretsadik T, Shintani AK, Sokka T, et al. Increased coronary-artery atherosclerosis in rheumatoid arthritis: relationship to disease duration and cardiovascular risk factors. Arthritis Rheum. 2005;52:3045–3053
  6. del Rincon I, Freeman GL, Haas RW, O'Leary DH, Escalante A. Relative contribution of cardiovascular risk factors and rheumatoid arthritis clinical manifestations to atherosclerosis. Arthritis Rheum. 2005;52:3413–3423
  7. Goodson NJ, Symmons DP, Scott DG, Bunn D, Lunt M, Silman AJ. Baseline levels of C-reactive protein and prediction of death from cardiovascular disease in patients with inflammatory polyarthritis: a ten-year followup study of a primary care-based inception cohort. Arthritis Rheum. 2005;52:2293–2299
  8. Maradit-Kremers H, Nicola PJ, Crowson CS, Ballman KV, Gabriel SE. Cardiovascular death in rheumatoid arthritis: a population-based study. Arthritis Rheum. 2005;52:722–732
  9. Gibbons RJ, Chatterjee K, Daley J, Douglas JS, Fihn SD, Gardin JM, et al. ACC/AHA/ACP–ASIM guidelines for the management of patients with chronic stable angina: executive summary and recommendations. Circulation. 1999;99:2829–2848
  10. Olmos LI, Dakik H, Gordon R, Dunn JK, Verani MS, Quinones MA, et al. Long-term prognostic value of exercise echocardiography compared with exercise 201Tl, ECG, and clinical variables in patients evaluated for coronary artery disease. Circulation. 1998;98:2679–2686
  11. Nagueh SF, Zoghbi WA. Stress echocardiography for the assessment of myocardial ischemia and viability. Curr Probl Cardiol. 1996;21:445–520
  12. Marwick TH, Case C, Vasey C, Allen S, Short L, Thomas JD. Prediction of mortality by exercise echocardiography: a strategy for combination with the Duke treadmill score. Circulation. 2001;103:2566–2571
  13. Bergeron S, Ommen SR, Bailey KR, Oh JK, McCully RB, Pellikka PA. Exercise echocardiographic findings and outcome of patients referred for evaluation of dyspnea. J Am Coll Cardiol. 2004;43:2242–2246
  14. Roger VL, Pellikka PA, Oh JK, Miller FA, Seward JB, Tajik AJ. Stress echocardiography. Part I. Exercise echocardiography: techniques, implementation, clinical applications, and correlations. Mayo Clin Proc. 1995;70:5–15
  15. Pellikka P, Nagueh S, Elhendy A, Kuehl CA, Sawada SG. American Society of Echocardiography. American Society of Echocardiography recommendations for performance, interpretation, and application of stress echocardiography. J Am Soc Echocardiogr. 2007;20:1021–1041
  16. Breslow NE, Day NE. Statistical methods in cancer research. Volume I—the analysis of case-control studies. IARC Sci Publ. 1980;32:5–338
  17. Gonzalez A, Maradit Kremers H, Crowson C, Nicola PJ, Davis JM, Therneau TM, et al. The widening mortality gap between rheumatoid arthritis and the general population. Arthritis Rheum. 2007;56:3583–3587
  18. Ciftci O, Yilmaz S, Topcu S, Caliskan M, Gullu H, Erdogan D, et al. Impaired coronary microvascular function and increased intima-media thickness in rheumatoid arthritis. Atherosclerosis. 2008;198:332–337
  19. Choi HK, Hernan MA, Seeger JD, Robins JM, Wolfe F. Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study. Lancet. 2002;359:1173–1177
  20. Lauer M, Blackstone E, Young J, Topol EJ. Cause of death in clinical research: Time for a reassessment?. J Am Coll Cardiol. 1999;34:618–620

PII: S0894-7317(09)00692-0

doi: 10.1016/j.echo.2009.07.018

Journal of the American Society of Echocardiography
Volume 22, Issue 11 , Pages 1228-1231 , November 2009

Article Tools

* Image Usage & Resolution